The first and only FDA-approved cannabidiol1

EPIDIOLEX® (cannabidiol) is a first-in-class AED for the treatment of seizures associated with LGS or Dravet syndrome in patients 2 years and older1

EPIDIOLEX is structurally distinct from other AEDs2

  • EPIDIOLEX is the first and only FDA-approved prescription cannabidiol1
  • EPIDIOLEX is believed to exert its anticonvulsant effects through multiple modes of action2
  • EPIDIOLEX does not appear to exert its anticonvulsant effect through interaction with cannabinoid receptors2
  • The precise mechanisms by which EPIDIOLEX exerts its anticonvulsant effect in humans are unknown